- Sinopec Shanghai’s FY IFRS net significantly surpassed estimates, reaching 1.35 billion yuan against an estimated 37.2 million yuan.
- The company reported a net loss of 1.41 billion yuan.
- Revenue increased by 13% year-on-year, amounting to 93.01 billion yuan.
- The IFRS revenue was also 93.01 billion yuan, slightly above the estimate of 92.88 billion yuan.
- The loss per share was 13 RMB cents.
- Opinions on the company’s performance varied: there were 5 buys, 3 holds, and 1 sell.
- All comparisons to past results are based on values reported by the company’s original disclosures.
A look at China Petroleum & Chemical Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Petroleum & Chemical Corporation, also known as Sinopec, has a bright future ahead according to the Smartkarma Smart Scores. With an overall score of 4 out of 5, the company is expected to perform well in the long-term. This is due to its high scores in value, dividend, and momentum, all of which are essential factors for a successful company.
Sinopec, which produces and trades petroleum and petrochemical products, has a strong value score of 5, indicating that its stock is currently undervalued. Additionally, the company has a perfect score of 5 in dividend, meaning it is expected to provide a steady income to its shareholders. Its above-average score of 4 in growth also suggests that Sinopec has potential for future expansion and increased profitability. While its resilience score of 3 is not as high as the others, Sinopec’s overall outlook is still positive and shows promise for long-term success in the petroleum and petrochemical industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
